Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:23
03/30/21
03/30
16:23
03/30/21
16:23
ILMN

Illumina

$368.18 /

-26.6 (-6.74%)

, PFE

Pfizer

$36.11 /

-0.51 (-1.39%)

, BNTX

BioNTech

$104.41 /

+8.67 (+9.06%)

, PYPL

PayPal

$236.67 /

+1 (+0.42%)

, V

Visa

$211.76 /

-2.76 (-1.29%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

, SPOT

Spotify

$257.38 /

+4.93 (+1.95%)

, DKNG

DraftKings

$61.04 /

+2.84 (+4.88%)

, DXC

DXC Technology

$31.15 /

+2.64 (+9.26%)

, AAL

American Airlines

$24.14 /

+1.24 (+5.41%)

, WVE

Wave Life Sciences

$5.93 /

-1.165 (-16.43%)

, GOEV

Canoo

$9.26 /

-2.48 (-21.12%)

Stock were mixed on…

ShowHide Related Items >><<
WVE Wave Life Sciences
$5.93 /

-1.165 (-16.43%)

V Visa
$211.76 /

-2.76 (-1.29%)

SPOT Spotify
$257.38 /

+4.93 (+1.95%)

PYPL PayPal
$236.67 /

+1 (+0.42%)

PFE Pfizer
$36.11 /

-0.51 (-1.39%)

ILMN Illumina
$368.18 /

-26.6 (-6.74%)

GOEV Canoo
$9.26 /

-2.48 (-21.12%)

DXC DXC Technology
$31.15 /

+2.64 (+9.26%)

DKNG DraftKings
$61.04 /

+2.84 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BNTX BioNTech
$104.41 /

+8.67 (+9.06%)

AAL American Airlines
$24.14 /

+1.24 (+5.41%)

ILMN Illumina
$368.18 /

-26.6 (-6.74%)

03/31/21 Canaccord
Canaccord upgrades Illumina, says worth owning with or without Grail
03/31/21 Canaccord
Illumina upgraded to Buy from Hold at Canaccord
03/31/21 Atlantic Equities
Illumina downgraded to Neutral from Overweight at Atlantic Equities
03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
PFE Pfizer
$36.11 /

-0.51 (-1.39%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
BNTX BioNTech
$104.41 /

+8.67 (+9.06%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PYPL PayPal
$236.67 /

+1 (+0.42%)

03/19/21 Susquehanna
PayPal chances of crypto success likely, says Susquehanna
03/12/21
Fly Intel: Top five analyst initiations
03/12/21 Redburn
PayPal initiated with a Buy at Redburn
03/12/21 Redburn
PayPal initiated with a Buy at Redburn
V Visa
$211.76 /

-2.76 (-1.29%)

03/19/21 JPMorgan
Visa has 'navigated heavy regulatory oversight' before, says JPMorgan
03/19/21 Wells Fargo
Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo
03/19/21 Barclays
Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays
03/16/21 Morgan Stanley
Visa price target raised to $253 from $233 at Morgan Stanley
BTC Bitcoin
$0.00 /

+ (+0.00%)

01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
SPOT Spotify
$257.38 /

+4.93 (+1.95%)

03/23/21 China Renaissance
China Renaissance downgrades Tencent Music to Hold after Q4 earnings
02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 JPMorgan
Spotify price target raised to $385 from $350 at JPMorgan
02/23/21 Atlantic Equities
Spotify downgraded to Neutral from Overweight at Atlantic Equities
DKNG DraftKings
$61.04 /

+2.84 (+4.88%)

03/30/21 Loop Capital
Loop Capital recommends buying DraftKings going into NY budget deadline
03/23/21 Goldman Sachs
DraftKings price target raised to $87 from $79 at Goldman Sachs
03/18/21 JPMorgan
Micro-betting market in U.S. 'could be substantial,' says JPMorgan
03/14/21 Jefferies
FanDuel IPO in U.S. would be 'major catalyst' for Flutter stock, says Jefferies
DXC DXC Technology
$31.15 /

+2.64 (+9.26%)

03/30/21 Deutsche Bank
Deutsche upgrades 'cleaned up' DXC to Buy with $44 price target
03/29/21 Deutsche Bank
DXC Technology upgraded to Buy from Hold at Deutsche Bank
02/19/21 BofA
BofA upgrades DXC Technology to Neutral, says 'worst is likely over'
02/19/21 BofA
DXC Technology upgraded to Neutral from Underperform at BofA
AAL American Airlines
$24.14 /

+1.24 (+5.41%)

03/30/21
Fly Intel: Top five analyst upgrades
03/30/21 Jefferies
Jefferies upgrades American Airlines to Hold on outperformance potential
03/30/21 Citi
Citi takes 'cautious view' on American Airlines capacity additions
03/30/21 Jefferies
American Airlines upgraded to Hold from Underperform at Jefferies
WVE Wave Life Sciences
$5.93 /

-1.165 (-16.43%)

03/30/21 Truist
Wave Life Sciences price target lowered to $17 from $27 at Truist
03/30/21 Mizuho
Wave Life Sciences price target lowered to $7 from $21 at Mizuho
03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
GOEV Canoo
$9.26 /

-2.48 (-21.12%)

03/30/21 Roth Capital
Canoo downgraded to Neutral at Roth Capital on 'complete change in direction'
03/30/21 Roth Capital
Canoo downgraded to Neutral from Buy at Roth Capital
03/11/21 R.F. Lafferty
Canoo initiated with a Buy at R.F. Lafferty
WVE Wave Life Sciences
$5.93 /

-1.165 (-16.43%)

V Visa
$211.76 /

-2.76 (-1.29%)

SPOT Spotify
$257.38 /

+4.93 (+1.95%)

PYPL PayPal
$236.67 /

+1 (+0.42%)

PFE Pfizer
$36.11 /

-0.51 (-1.39%)

ILMN Illumina
$368.18 /

-26.6 (-6.74%)

GOEV Canoo
$9.26 /

-2.48 (-21.12%)

DXC DXC Technology
$31.15 /

+2.64 (+9.26%)

DKNG DraftKings
$61.04 /

+2.84 (+4.88%)

AAL American Airlines
$24.14 /

+1.24 (+5.41%)

  • 10
    Nov
  • 13
    Oct
  • 07
    Oct
  • 23
    Sep
  • 23
    Jul
  • 23
    Jun
  • 19
    Jun
V Visa
$211.76 /

-2.76 (-1.29%)

SPOT Spotify
$257.38 /

+4.93 (+1.95%)

PYPL PayPal
$236.67 /

+1 (+0.42%)

PFE Pfizer
$36.11 /

-0.51 (-1.39%)

ILMN Illumina
$368.18 /

-26.6 (-6.74%)

GOEV Canoo
$9.26 /

-2.48 (-21.12%)

DXC DXC Technology
$31.15 /

+2.64 (+9.26%)

DKNG DraftKings
$61.04 /

+2.84 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BNTX BioNTech
$104.41 /

+8.67 (+9.06%)

AAL American Airlines
$24.14 /

+1.24 (+5.41%)

WVE Wave Life Sciences
$5.93 /

-1.165 (-16.43%)

V Visa
$211.76 /

-2.76 (-1.29%)

SPOT Spotify
$257.38 /

+4.93 (+1.95%)

PYPL PayPal
$236.67 /

+1 (+0.42%)

PFE Pfizer
$36.11 /

-0.51 (-1.39%)

ILMN Illumina
$368.18 /

-26.6 (-6.74%)

GOEV Canoo
$9.26 /

-2.48 (-21.12%)

DXC DXC Technology
$31.15 /

+2.64 (+9.26%)

DKNG DraftKings
$61.04 /

+2.84 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

AAL American Airlines
$24.14 /

+1.24 (+5.41%)

V Visa
$211.76 /

-2.76 (-1.29%)

SPOT Spotify
$257.38 /

+4.93 (+1.95%)

PYPL PayPal
$236.67 /

+1 (+0.42%)

PFE Pfizer
$36.11 /

-0.51 (-1.39%)

ILMN Illumina
$368.18 /

-26.6 (-6.74%)

GOEV Canoo
$9.26 /

-2.48 (-21.12%)

DXC DXC Technology
$31.15 /

+2.64 (+9.26%)

DKNG DraftKings
$61.04 /

+2.84 (+4.88%)

BNTX BioNTech
$104.41 /

+8.67 (+9.06%)

AAL American Airlines
$24.14 /

+1.24 (+5.41%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:55
03/30/21
03/30
12:55
03/30/21
12:55
PFE

Pfizer

$36.15 /

-0.47 (-1.28%)

, BNTX

BioNTech

$104.09 /

+8.35 (+8.72%)

, PYPL

PayPal

$235.82 /

+0.15 (+0.06%)

, V

Visa

$212.18 /

-2.34 (-1.09%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

, MKC

McCormick

$91.17 /

+0.985 (+1.09%)

, ABCL

AbCellera

$25.16 /

+1.805 (+7.73%)

, WVE

Wave Life Sciences

$5.04 /

-2.055 (-28.98%)

, GOEV

Canoo

$9.29 /

-2.45 (-20.87%)

The major averages are…

ShowHide Related Items >><<
WVE Wave Life Sciences
$5.04 /

-2.055 (-28.98%)

V Visa
$212.18 /

-2.34 (-1.09%)

PYPL PayPal
$235.82 /

+0.15 (+0.06%)

PFE Pfizer
$36.15 /

-0.47 (-1.28%)

MKC McCormick
$91.17 /

+0.985 (+1.09%)

GOEV Canoo
$9.29 /

-2.45 (-20.87%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BNTX BioNTech
$104.09 /

+8.35 (+8.72%)

ABCL AbCellera
$25.16 /

+1.805 (+7.73%)

PFE Pfizer
$36.15 /

-0.47 (-1.28%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
BNTX BioNTech
$104.09 /

+8.35 (+8.72%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PYPL PayPal
$235.82 /

+0.15 (+0.06%)

03/19/21 Susquehanna
PayPal chances of crypto success likely, says Susquehanna
03/12/21
Fly Intel: Top five analyst initiations
03/12/21 Redburn
PayPal initiated with a Buy at Redburn
03/12/21 Redburn
PayPal initiated with a Buy at Redburn
V Visa
$212.18 /

-2.34 (-1.09%)

03/19/21 JPMorgan
Visa has 'navigated heavy regulatory oversight' before, says JPMorgan
03/19/21 Wells Fargo
Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo
03/19/21 Barclays
Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays
03/16/21 Morgan Stanley
Visa price target raised to $253 from $233 at Morgan Stanley
BTC Bitcoin
$0.00 /

+ (+0.00%)

01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
MKC McCormick
$91.17 /

+0.985 (+1.09%)

03/17/21
Fly Intel: Top five analyst downgrades
03/17/21 Argus
McCormick downgraded to Hold at Argus on weaker outlook post-pandemic
03/17/21 Argus
McCormick downgraded to Hold from Buy at Argus
11/24/20 Stifel
Stifel sees McCormick's acquisition of Cholula brand as 'strategic'
ABCL AbCellera
$25.16 /

+1.805 (+7.73%)

03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
01/26/21 Berenberg
Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
WVE Wave Life Sciences
$5.04 /

-2.055 (-28.98%)

03/30/21 Truist
Wave Life Sciences price target lowered to $17 from $27 at Truist
03/30/21 Mizuho
Wave Life Sciences price target lowered to $7 from $21 at Mizuho
03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
GOEV Canoo
$9.29 /

-2.45 (-20.87%)

03/30/21 Roth Capital
Canoo downgraded to Neutral at Roth Capital on 'complete change in direction'
03/30/21 Roth Capital
Canoo downgraded to Neutral from Buy at Roth Capital
03/11/21 R.F. Lafferty
Canoo initiated with a Buy at R.F. Lafferty
WVE Wave Life Sciences
$5.04 /

-2.055 (-28.98%)

V Visa
$212.18 /

-2.34 (-1.09%)

PYPL PayPal
$235.82 /

+0.15 (+0.06%)

PFE Pfizer
$36.15 /

-0.47 (-1.28%)

MKC McCormick
$91.17 /

+0.985 (+1.09%)

GOEV Canoo
$9.29 /

-2.45 (-20.87%)

ABCL AbCellera
$25.16 /

+1.805 (+7.73%)

  • 11
    Dec
  • 13
    Oct
  • 23
    Sep
  • 23
    Jul
V Visa
$212.18 /

-2.34 (-1.09%)

PYPL PayPal
$235.82 /

+0.15 (+0.06%)

PFE Pfizer
$36.15 /

-0.47 (-1.28%)

GOEV Canoo
$9.29 /

-2.45 (-20.87%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BNTX BioNTech
$104.09 /

+8.35 (+8.72%)

WVE Wave Life Sciences
$5.04 /

-2.055 (-28.98%)

V Visa
$212.18 /

-2.34 (-1.09%)

PYPL PayPal
$235.82 /

+0.15 (+0.06%)

PFE Pfizer
$36.15 /

-0.47 (-1.28%)

MKC McCormick
$91.17 /

+0.985 (+1.09%)

GOEV Canoo
$9.29 /

-2.45 (-20.87%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

ABCL AbCellera
$25.16 /

+1.805 (+7.73%)

V Visa
$212.18 /

-2.34 (-1.09%)

PYPL PayPal
$235.82 /

+0.15 (+0.06%)

PFE Pfizer
$36.15 /

-0.47 (-1.28%)

MKC McCormick
$91.17 /

+0.985 (+1.09%)

GOEV Canoo
$9.29 /

-2.45 (-20.87%)

BNTX BioNTech
$104.09 /

+8.35 (+8.72%)

ABCL AbCellera
$25.16 /

+1.805 (+7.73%)

On The Fly
Fly Intel: Pre-market Movers » 08:54
03/30/21
03/30
08:54
03/30/21
08:54
PFE

Pfizer

$36.62 /

+0.37 (+1.02%)

, BNTX

BioNTech

$95.74 /

+0.21 (+0.22%)

, QIWI

Qiwi

$10.40 /

+0.24 (+2.36%)

, VIPS

Vipshop

$28.48 /

-2.66 (-8.54%)

, ANGO

AngioDynamics

$20.90 /

-0.14 (-0.67%)

, MCK

McKesson

$195.99 /

+1.99 (+1.03%)

, PCVX

Vaxcyte

$22.76 /

-1.02 (-4.29%)

, DNMR

Danimer Scientific

$36.99 /

-1.605 (-4.16%)

, SEAC

SeaChange

$2.08 /

+1.055 (+102.93%)

, WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

, ABCL

AbCellera

$23.29 /

-1.5 (-6.05%)

Check out this morning's…

ShowHide Related Items >><<
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VIPS Vipshop
$28.48 /

-2.66 (-8.54%)

SEAC SeaChange
$2.08 /

+1.055 (+102.93%)

QIWI Qiwi
$10.40 /

+0.24 (+2.36%)

PFE Pfizer
$36.62 /

+0.37 (+1.02%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

MCK McKesson
$195.99 /

+1.99 (+1.03%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

BNTX BioNTech
$95.74 /

+0.21 (+0.22%)

ANGO AngioDynamics
$20.90 /

-0.14 (-0.67%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

PFE Pfizer
$36.62 /

+0.37 (+1.02%)

03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
BNTX BioNTech
$95.74 /

+0.21 (+0.22%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
QIWI Qiwi
$10.40 /

+0.24 (+2.36%)

12/11/20 Goldman Sachs
Qiwi downgraded to Neutral from Buy at Goldman Sachs
12/10/20 William Blair
Qiwi government audit to bring business changes, says William Blair
12/09/20 JPMorgan
Qiwi downgraded to Underweight from Neutral at JPMorgan
11/23/20
Qiwi downgraded to Sell from Buy at Sberbank CIB
VIPS Vipshop
$28.48 /

-2.66 (-8.54%)

02/26/21 Macquarie
Vipshop price target raised to $52 from $33 at Macquarie
02/01/21 Morgan Stanley
Vipshop user engagement to underpin 'solid' user growth, says Morgan Stanley
02/01/21 Morgan Stanley
Vipshop upgraded to Overweight from Underweight at Morgan Stanley
01/26/21 KeyBanc
Vipshop downgraded to Sector Weight at KeyBanc on lack of drivers
ANGO AngioDynamics
$20.90 /

-0.14 (-0.67%)

01/08/21 Canaccord
AngioDynamics price target raised to $18 from $14 at Canaccord
11/25/20
Fly Intel: Top five analyst upgrades
11/25/20 Raymond James
Raymond James upgrades AngioDynamics to Strong Buy on 'compelling' risk/reward
11/25/20 Raymond James
AngioDynamics upgraded to Strong Buy from Market Perform at Raymond James
MCK McKesson
$195.99 /

+1.99 (+1.03%)

03/30/21 Argus
McKesson upgraded to Buy from Hold at Argus
03/02/21 Cowen
McKesson price target raised to $224 from $210 at Cowen
02/03/21 Credit Suisse
McKesson price target raised to $192 from $178 at Credit Suisse
02/03/21 Deutsche Bank
McKesson price target raised to $231 from $222 at Deutsche Bank
PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

02/09/21 Jefferies
Danimer Scientific price target raised to $66 from $49 at Jefferies
01/06/21 Jefferies
Danimer Scientific initiated with a Buy at Jefferies
SEAC SeaChange
$2.08 /

+1.055 (+102.93%)

09/09/20 Lake Street
SeaChange price target lowered to $2 from $4 at Lake Street
04/08/20
SeaChange participates in a conference call hosted by Lake Street
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/30/21 Truist
Wave Life Sciences price target lowered to $17 from $27 at Truist
03/30/21 Mizuho
Wave Life Sciences price target lowered to $7 from $21 at Mizuho
03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
01/26/21 Berenberg
Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VIPS Vipshop
$28.48 /

-2.66 (-8.54%)

QIWI Qiwi
$10.40 /

+0.24 (+2.36%)

PFE Pfizer
$36.62 /

+0.37 (+1.02%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

MCK McKesson
$195.99 /

+1.99 (+1.03%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

ANGO AngioDynamics
$20.90 /

-0.14 (-0.67%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

  • 11
    Dec
  • 23
    Sep
  • 23
    Jul
  • 22
    Jul
  • 12
    Jun
VIPS Vipshop
$28.48 /

-2.66 (-8.54%)

PFE Pfizer
$36.62 /

+0.37 (+1.02%)

MCK McKesson
$195.99 /

+1.99 (+1.03%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

BNTX BioNTech
$95.74 /

+0.21 (+0.22%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VIPS Vipshop
$28.48 /

-2.66 (-8.54%)

SEAC SeaChange
$2.08 /

+1.055 (+102.93%)

QIWI Qiwi
$10.40 /

+0.24 (+2.36%)

PFE Pfizer
$36.62 /

+0.37 (+1.02%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

MCK McKesson
$195.99 /

+1.99 (+1.03%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

BNTX BioNTech
$95.74 /

+0.21 (+0.22%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

VIPS Vipshop
$28.48 /

-2.66 (-8.54%)

QIWI Qiwi
$10.40 /

+0.24 (+2.36%)

PFE Pfizer
$36.62 /

+0.37 (+1.02%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

MCK McKesson
$195.99 /

+1.99 (+1.03%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

BNTX BioNTech
$95.74 /

+0.21 (+0.22%)

Recommendations
Wave Life Sciences price target lowered to $17 from $27 at Truist » 08:20
03/30/21
03/30
08:20
03/30/21
08:20
WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

Truist analyst Joon Lee…

Truist analyst Joon Lee lowered the firm's price target on Wave Life Sciences to $17 from $27 but keeps a Buy rating on the shares. The company's failed Huntington's disease trial data were disappointing, with SNPs 1 and 2 results leading to the programs beeing terminated, however its HD-SNP3 program - supported by in vivo knockdown data - will still advance to the clinic in 2021, the analyst tells investors in a research note. Lee adds that he remains positive on Wave Life's clean break from the older oligo platform, with focus on 5 major programs.

ShowHide Related Items >><<
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/30/21 Mizuho
Wave Life Sciences price target lowered to $7 from $21 at Mizuho
03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

  • 23
    Sep
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

Recommendations
Wave Life Sciences price target lowered to $7 from $21 at Mizuho » 07:01
03/30/21
03/30
07:01
03/30/21
07:01
WVE

Wave Life Sciences

/

+

Mizuho analyst Salim Syed…

Mizuho analyst Salim Syed lowered the firm's price target on Wave Life Sciences to $7 from $21 and keeps a Buy rating on the shares after the company's Phase 1b/2a Huntington's disease data failed on efficacy. "It didn't even get close to hitting what we had thought of as target range mHTT knockdown of 20-30%," Syed tells investors in a research note. The analyst believes the data "should be effectively the last of the weaker" first-generation chemistry from Wave Life, potentially marking a "clearing event from an investor sentiment point of view."

ShowHide Related Items >><<
WVE Wave Life Sciences
/

+

WVE Wave Life Sciences
/

+

03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
WVE Wave Life Sciences
/

+

  • 23
    Sep
WVE Wave Life Sciences
/

+

Recommendations
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital » 06:51
03/30/21
03/30
06:51
03/30/21
06:51
WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

RBC Capital analyst Luca…

RBC Capital analyst Luca Issi lowered the firm's price target on Wave Life Sciences to $8 from $13 and keeps a Sector Perform rating on the shares. The company's Huntington's data affirmed his "low conviction" as results showed "no target engagement, no dose response, and no clinical improvement", leading to the program being discontinued, the analyst tells investors in a research note. Issi adds that while novel chemistry is more potent in animal models, he sees Wave Life Sciences as a "show-me story" given that it now had two failed clinical programs.

ShowHide Related Items >><<
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

  • 23
    Sep
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

On The Fly
Fly Intel: After-Hours Movers » 18:47
03/29/21
03/29
18:47
03/29/21
18:47
ABCL

AbCellera

$23.29 /

-1.5 (-6.05%)

, VTSI

VirTra

$4.75 /

+0.05 (+1.06%)

, SRAX

Srax

$4.50 /

+0.315 (+7.54%)

, BIOC

Biocept

$5.15 /

-0.545 (-9.58%)

, LYRA

Lyra Therapeutics

$11.30 /

-0.62 (-5.20%)

, PLMR

Palomar

$65.96 /

-3.44 (-4.96%)

, PSNL

Personalis

$20.77 /

-1.28 (-5.80%)

, SHAK

Shake Shack

$110.70 /

-3.84 (-3.35%)

, PCVX

Vaxcyte

$22.76 /

-1.02 (-4.29%)

, DNMR

Danimer Scientific

$36.99 /

-1.605 (-4.16%)

, CLDX

Celldex

$20.50 /

-3.51 (-14.62%)

, GOEV

Canoo

$11.74 /

-0.72 (-5.78%)

, USIO

Usio

$6.31 /

-0.39 (-5.82%)

, WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

, BFLY

Butterfly Network

$18.09 /

+0.09 (+0.50%)

, YTEN

Yield10 Bioscience

$11.68 /

-0.7 (-5.65%)

Check out this evening's…

ShowHide Related Items >><<
YTEN Yield10 Bioscience
$11.68 /

-0.7 (-5.65%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VTSI VirTra
$4.75 /

+0.05 (+1.06%)

USIO Usio
$6.31 /

-0.39 (-5.82%)

SRAX Srax
$4.50 /

+0.315 (+7.54%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

PSNL Personalis
$20.77 /

-1.28 (-5.80%)

PLMR Palomar
$65.96 /

-3.44 (-4.96%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

LYRA Lyra Therapeutics
$11.30 /

-0.62 (-5.20%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

CLDX Celldex
$20.50 /

-3.51 (-14.62%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
01/26/21 Berenberg
Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
01/25/21 BMO Capital
AbCellera price target raised to $61 from $48 at BMO Capital
VTSI VirTra
$4.75 /

+0.05 (+1.06%)

02/12/21 Maxim
VirTra assumed with a Buy at Maxim
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 Roth Capital
VirTra resumed with a Buy at Roth Capital
SRAX Srax
$4.50 /

+0.315 (+7.54%)

02/12/21 B. Riley
Srax price target raised to $7.50 from $4.50 at B. Riley Securities
02/08/21 Ladenburg
Srax initiated with a Buy at Ladenburg
01/29/21 B. Riley
Srax price target raised to $4.50 from $4 at B. Riley Securities
07/06/20
Fly Intel: Top five analyst initiations
BIOC Biocept
$5.15 /

-0.545 (-9.58%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
LYRA Lyra Therapeutics
$11.30 /

-0.62 (-5.20%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
05/26/20 BTIG
Lyra Therapeutics initiated with a Buy at BTIG
05/26/20 Jefferies
Jefferies starts Lyra Therapeutics at Buy with $24 price target
05/26/20 BofA
BofA starts Lyra Therapeutics at Buy with $21 price target
PLMR Palomar
$65.96 /

-3.44 (-4.96%)

03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Barclays
Palomar upgraded to Overweight from Equal Weight at Barclays
02/23/21 Keefe Bruyette
Palomar recent selloff on Uri 'very overdone,' says Keefe Bruyette
01/12/21 Barclays
Palomar price target raised to $94 from $82 at Barclays
PSNL Personalis
$20.77 /

-1.28 (-5.80%)

02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Needham
Personalis assumed with a Buy at Needham
01/27/21 Truist
Personalis initiated with a Buy at Truist
01/04/21 BofA
Personalis downgraded to Neutral on valuation at BofA
SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

03/18/21 Truist
Shake Shack price target raised to $105 from $99 at Truist
03/04/21 Deutsche Bank
Shake Shack price target raised to $107 from $70 at Deutsche Bank
02/26/21 Loop Capital
Shake Shack price target raised to $150 from $120 at Loop Capital
02/26/21 Barclays
Shake Shack price target raised to $100 from $86 at Barclays
PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

02/09/21 Jefferies
Danimer Scientific price target raised to $66 from $49 at Jefferies
01/06/21 Jefferies
Danimer Scientific initiated with a Buy at Jefferies
CLDX Celldex
$20.50 /

-3.51 (-14.62%)

03/29/21 H.C. Wainwright
Celldex selloff on CDX-0159 data 'undeserved,' says H.C. Wainwright
02/23/21 H.C. Wainwright
Celldex price target raised to $36 from $25 at H.C. Wainwright
02/23/21 Cantor Fitzgerald
Celldex price target raised to $35 from $22 at Cantor Fitzgerald
10/19/20 H.C. Wainwright
Celldex price target raised to $25 from $16 at H.C. Wainwright
GOEV Canoo
$11.74 /

-0.72 (-5.78%)

03/11/21 R.F. Lafferty
Canoo initiated with a Buy at R.F. Lafferty
USIO Usio
$6.31 /

-0.39 (-5.82%)

02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
05/07/20
Fly Intel: Top five analyst initiations
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

YTEN Yield10 Bioscience
$11.68 /

-0.7 (-5.65%)

02/10/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
02/09/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
01/19/21 H.C. Wainwright
Yield10 Bioscience proof-of-concept validates pipeline, says H.C. Wainwright
09/10/20 H.C. Wainwright
Yield10 Bioscience initiated with a Buy at H.C. Wainwright
YTEN Yield10 Bioscience
$11.68 /

-0.7 (-5.65%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VTSI VirTra
$4.75 /

+0.05 (+1.06%)

USIO Usio
$6.31 /

-0.39 (-5.82%)

SRAX Srax
$4.50 /

+0.315 (+7.54%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

PSNL Personalis
$20.77 /

-1.28 (-5.80%)

PLMR Palomar
$65.96 /

-3.44 (-4.96%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

LYRA Lyra Therapeutics
$11.30 /

-0.62 (-5.20%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

CLDX Celldex
$20.50 /

-3.51 (-14.62%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

  • 01
    Feb
  • 27
    Jan
  • 11
    Dec
  • 23
    Sep
  • 23
    Sep
  • 12
    Aug
  • 24
    Jun
  • 16
    Jun
  • 12
    Jun
  • 01
    May
  • 14
    Apr
GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

USIO Usio
$6.31 /

-0.39 (-5.82%)

SRAX Srax
$4.50 /

+0.315 (+7.54%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

PSNL Personalis
$20.77 /

-1.28 (-5.80%)

PLMR Palomar
$65.96 /

-3.44 (-4.96%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

CLDX Celldex
$20.50 /

-3.51 (-14.62%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

Hot Stocks
Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials » 16:21
03/29/21
03/29
16:21
03/29/21
16:21
WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

Wave Life Sciences…

Wave Life Sciences announced data from the Phase 1b/2a PRECISION-HD2 and PRECISION-HD1 trials evaluating investigational treatments WVE-120102 and WVE-120101, respectively, in Huntington's disease (HD). In the PRECISION-HD2 core trial, results from all participants (n=88) showed no statistically significant change in mutant huntingtin protein, mHTT versus placebo after single or multiple doses of WVE-120102 up to and including 32 mg monthly. There was no evidence of a dose response across the dose levels tested.

ShowHide Related Items >><<
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

  • 23
    Sep
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

Hot Stocks
Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials » 16:21
03/29/21
03/29
16:21
03/29/21
16:21
WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

Wave Life Sciences…

Wave Life Sciences announced data from the Phase 1b/2a PRECISION-HD2 and PRECISION-HD1 trials evaluating investigational treatments WVE-120102 and WVE-120101, respectively, in Huntington's disease (HD). In the PRECISION-HD2 core trial, results from all participants (n=88) showed no statistically significant change in mutant huntingtin protein, mHTT versus placebo after single or multiple doses of WVE-120102 up to and including 32 mg monthly. There was no evidence of a dose response across the dose levels tested.

ShowHide Related Items >><<
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

  • 23
    Sep
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

On The Fly
Ionis Pharmaceuticals slides as Wall Street digests HD program setback » 14:09
03/23/21
03/23
14:09
03/23/21
14:09
QURE

uniQure

$31.80 /

-2.77 (-8.01%)

, IONS

Ionis Pharmaceuticals

$44.30 /

-11.33 (-20.37%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, WVE

Wave Life Sciences

$8.37 /

-2.165 (-20.56%)

, PTCT

PTC Therapeutics

$52.58 /

-4.5 (-7.88%)

Shares of Ionis…

ShowHide Related Items >><<
WVE Wave Life Sciences
$8.37 /

-2.165 (-20.56%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$31.80 /

-2.77 (-8.01%)

PTCT PTC Therapeutics
$52.58 /

-4.5 (-7.88%)

IONS Ionis Pharmaceuticals
$44.30 /

-11.33 (-20.37%)

QURE uniQure
$31.80 /

-2.77 (-8.01%)

03/02/21 Chardan
uniQure price target raised to $100 from $85 at Chardan
12/22/20 Chardan
uniQure selloff on clinical hold brings good entry point, says Chardan
12/22/20 Jefferies
uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies
12/22/20 RBC Capital
uniQure price target lowered to $53 from $61 at RBC Capital
IONS Ionis Pharmaceuticals
$44.30 /

-11.33 (-20.37%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
03/23/21 Cowen
Ionis Pharmaceuticals HD program halt removes overhang, says Cowen
03/23/21 Morgan Stanley
Ionis Pharmaceuticals price target lowered to $43 from $50 at Morgan Stanley
RHHBY Roche
$0.00 /

+ (+0.00%)

03/23/21 RBC Capital
Ionis Pharmaceuticals price target lowered to $65 from $76 at RBC Capital
WVE Wave Life Sciences
$8.37 /

-2.165 (-20.56%)

03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
PTCT PTC Therapeutics
$52.58 /

-4.5 (-7.88%)

02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
01/05/21 Citi
PTC Therapeutics upgraded to Buy from Neutral at Citi
WVE Wave Life Sciences
$8.37 /

-2.165 (-20.56%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$31.80 /

-2.77 (-8.01%)

PTCT PTC Therapeutics
$52.58 /

-4.5 (-7.88%)

IONS Ionis Pharmaceuticals
$44.30 /

-11.33 (-20.37%)

  • 23
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$31.80 /

-2.77 (-8.01%)

IONS Ionis Pharmaceuticals
$44.30 /

-11.33 (-20.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.